Hunjadi, Monika
Lamina, Claudia
Kahler, Patrick
Bernscherer, Tamara
Viikari, Jorma
Lehtimäki, Terho
Kähönen, Mika
Hurme, Mikko
Juonala, Markus
Taittonen, Leena
Laitinen, Tomi
Jokinen, Eero
Tossavainen, Päivi
Hutri-Kähönen, Nina
Raitakari, Olli
Ritsch, Andreas
Funding for this research was provided by:
Austrian Science Foundation FWF, Vienna, Austria (P27116-B23 to AR)
Austrian Atherosclersosis Society
Academy of Finland (286284, 134309 (Eye), 126925, 121584, 124282, 129378 (Salve), 117787 (Gendi), 41071 (Skidi), 322098)
the Social Insurance Institution of Finland
Competitive State Research Financing of the Expert Responsibility area of Kuopio, Tampere and Turku University Hospitals (X51001)
Juho Vainio Foundation
Paavo Nurmi Foundation
Finnish Foundation for Cardiovascular Research
Finnish Cultural Foundation
The Sigrid Juselius Foundation
Tampere Tuberculosis Foundation
Emil Aaltonen Foundation
Yrjö Jahnsson Foundation
Signe and Ane Gyllenberg Foundation
Diabetes Research Foundation of Finnish Diabetes Association
EU Horizon 2020 (755320 for TAXINOMISIS)
European Research Council (742927 for MULTIEPIGEN project)
Tampere University Hospital Supporting Foundation
Article History
Received: 10 June 2020
Accepted: 20 October 2020
First Online: 5 November 2020
Competing interests
: The authors declare no competing interests.